Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Omeprazole 20mg gastro-resistant capsules
0103050P0AAAAAA
|
Omeprazole | Omeprazole | Gastro-Intestinal System | 3,091,077 |
|
Lansoprazole 30mg gastro-resistant capsules
0103050L0AAAAAA
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | 2,304,121 |
|
Lansoprazole 15mg gastro-resistant capsules
0103050L0AAABAB
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | 1,623,512 |
|
Senna 7.5mg tablets
0106020M0AAACAC
|
Senna | Senna | Gastro-Intestinal System | 443,165 |
|
Omeprazole 10mg gastro-resistant capsules
0103050P0AAAFAF
|
Omeprazole | Omeprazole | Gastro-Intestinal System | 372,302 |
|
Lactulose 3.1-3.7g/5ml oral solution
0106040G0AAAAAA
|
Lactulose | Lactulose | Gastro-Intestinal System | 336,022 |
|
Famotidine 20mg tablets
0103010H0AAAAAA
|
Famotidine | Famotidine | Gastro-Intestinal System | 303,437 |
|
Laxido Orange oral powder sachets sugar free
0106040M0BCACAA
|
Laxido | Macrogol 3350 | Gastro-Intestinal System | 302,779 |
|
Macrogol compound oral powder sachets NPF sugar free
0106040M0AAAAAA
|
Macrogol 3350 | Macrogol 3350 | Gastro-Intestinal System | 267,068 |
|
Mebeverine 135mg tablets
0102000P0AAABAB
|
Mebeverine hydrochloride | Mebeverine hydrochloride | Gastro-Intestinal System | 253,637 |
|
Docusate 100mg capsules
0106020I0AAAKAK
|
Docusate sodium (Systemic) | Docusate sodium | Gastro-Intestinal System | 214,072 |
|
Omeprazole 40mg gastro-resistant capsules
0103050P0AAAEAE
|
Omeprazole | Omeprazole | Gastro-Intestinal System | 209,189 |
|
Pantoprazole 20mg gastro-resistant tablets
0103050R0AAABAB
|
Pantoprazole | Pantoprazole | Gastro-Intestinal System | 180,241 |
|
Pantoprazole 40mg gastro-resistant tablets
0103050R0AAAAAA
|
Pantoprazole | Pantoprazole | Gastro-Intestinal System | 177,715 |
|
Gaviscon Advance oral susp peppermint (Reckitt Benckiser)
0101021B0BEBEAL
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 177,286 |
|
Lansoprazole 30mg orodispersible tablets
0103050L0AAAHAH
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | 177,092 |
|
Peptac liquid peppermint
0101021B0BIABAH
|
Peptac | Alginic acid compound preparations | Gastro-Intestinal System | 171,508 |
|
Esomeprazole 20mg gastro-resistant capsules
0103050E0AAAFAF
|
Esomeprazole | Esomeprazole | Gastro-Intestinal System | 169,382 |
|
Hyoscine butylbromide 10mg tablets
0102000N0AAABAB
|
Hyoscine butylbromide | Hyoscine butylbromide | Gastro-Intestinal System | 156,555 |
|
Loperamide 2mg capsules
0104020L0AAAAAA
|
Loperamide hydrochloride | Loperamide hydrochloride | Gastro-Intestinal System | 147,391 |
|
Bisacodyl 5mg gastro-resistant tablets
0106020C0AAAAAA
|
Bisacodyl | Bisacodyl | Gastro-Intestinal System | 133,711 |
|
Esomeprazole 40mg gastro-resistant capsules
0103050E0AAAGAG
|
Esomeprazole | Esomeprazole | Gastro-Intestinal System | 129,508 |
|
Famotidine 40mg tablets
0103010H0AAABAB
|
Famotidine | Famotidine | Gastro-Intestinal System | 127,592 |
|
Gaviscon Advance oral suspension aniseed (Reckitt Benckiser)
0101021B0BEAIAL
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 126,592 |
|
Esomeprazole 20mg gastro-resistant tablets
0103050E0AAAAAA
|
Esomeprazole | Esomeprazole | Gastro-Intestinal System | 122,764 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.